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LONG AGO, Rous and Larimore (39) were intrigued 
with the possibility that portal venous blood con-
tained hepatotrophic factors and that the extra-
hepatic diversion of these factors by portacaval 
shunt was responsible for the poor health of dogs 
with Eck fistula. However, the observations of 
Mann (27) did not support the hepatotrophic 
hypothesis, and the work in 1953 of Child and his 
associates (11) using portacaval transposition was 
generally interpreted as crucial evidence against it. 
By replacing the diverted splanchnic venous blood 
with an inflow to the portal vein from the inferior 
vena cava, Child avoided most of the adverse 
effects of Eck fistula. The concept became rooted 
from these studies and those of Fisher and his asso-
ciates (15-17) and a number of subsequent authors 
that the quality of portal venous inflow was not a 
prime determinant of good hepatic structure, func-
tion, or capacity for regeneration. Instead, it be-
came accepted that the quantity of total hepatic 
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blood flow was the main consideration. In spite of 
the demonstration that canine livers submitted to 
transposition underwent major deglycogenation 
and were, thus, not actually normal (43, 52), the 
flow oriented view held sway until it was defini-
tively challenged by investigations that had their 
origin in studies of experimental liver transplanta-
tion as has been thoroughly reviewed in a recent 
monograph (50). 
First, it was noted that auxiliary hepatic homo-
grafts underwent remarkable atrophy if these extra 
livers were revascularized in an ectopic location 
with a double systemic blood supply analogous to 
that with the Child preparation (51). One possible 
explanation that was advanced was that the organ 
which was perfused first by splanchnic venous 
blood extracted a,disproportionate share of un-
specified substances and that the other organ 
atrophied because of its disadvantaged competitive 
situation. The hypothesis was supported by March-
ioro and his associates (29) who showed that the 
transplant atrophy could be prevented by diverting 
the nonhepatic splanchnic venous blood away from 
the host liver and through the graft. By so doing, 
the atrophy now afflicted the native organ. Con-
firmatory observations were reported by Thomford 
(56), Halgrimson (20), and Tretbar (57) and their 
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FIG. 1. Partial portacaval transposition. a and b, Entire vena caval flow 
is directed into either the left or the right portal venous branch. c and d, 
This differs from a and b in that the vena caval flow excludes the adrenal 
and renal blood. A venous graft is always required to bridge the gap. 
associates. Thomford (56) showed that the atrophy 
in Welch auxiliary homografts could be prevented 
in recipients which had undergone immunosup-
pression if the host livers were removed within a 
few days after transplantation, and Tretbar (57) 
and Halgrimson (20) and their colleagues demon-
strated that the shrinkage could be reduced by 
diversion of portal blood away from the host liver 
even though it was not directly rechanneled 
through the transplant. Observations by Sigel and 
his associates (47, 49) with hepatic autografts im-
planted to intestinal pedicles or directly revascular-
ized in the neck could be interpreted in the same 
general way. 
The transplant preparations which made ap-
parent the foregoing physiologic effects had two 
serious flaws which prevented definitive conclu-
sions about the pathogenesis of the atrophy. First, 
the total flows delivered to the two coexisting livers 
were often different. Second, there was by defini-
tion an additional inherent inequality of the two 
organs since the homograft was usually under 
immunologic attack despite host immunosuppres-
sion whereas the animal's own liver was not. Con-
sequently, other experiments were undertaken 
which were designed to circumvent one or both 
deficiencies. 
One preparation not involving transplantation 
was used by Marchioro and his associates (28, 30) 
and termed a split transposition. Splanchnic venous 
blood was provided for one portal vein branch of 
the liver whereas the other portal branch was sup-
plied with blood from the inferior vena cava. Later, 
Price (36), Lee (25), and Chandler (9) and their 
associates performed analogous experiments, with 
either canine partial hepatic autografts or isografts 
of inbred rat livers. All these experiments showed 
hypertrophy in the hepatic tissue which was per-
fused with splanchnic blood and atrophy of the 
other hepatic fragments. In addition to hyper-
trophy, Marchioro and his associates (28) showed 
that the advantaged hepatic portion had binucleate 
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FIG. 2. Technique of division of splanchnic venous flow into a pancreatico-
gastroduodenal-splenic compartment and an intestinal compartment. Blood from 
these respective sources is directed into the right or left lobes. The tail of the in-
ferior lobe of the pancreas was resected since it drains separately into the mesen-
teric vein. 
and trinucleate hepatic cells, mitoses, and prolifer-
ating bile ducts, all indications of hyperplasia. With 
quantitative studies of deoxyribonucleic acid syn-
thesis, Lee (25), Chandler (9) and Fisher (18) and 
their associates proved that the hepatotrophic 
effects of splanchnic blood upon the liver include 
hyperplasia as well as hypertrophy. It has become 
increasingly accepted that the portal hepatotrophic 
factors are probably not just artifacts of transplan-
tation and other experimental maneuvers but are 
prime determinants of the initiation and control of 
liver hypertrophy and hyperplasia in many cir-
cumstances. 
This article was undertaken to report anatomic 
and biochemical studies of the source and mecha-
nism of the hepatotrophic factors in splanchnic 
venous blood. The results have indicated that these 
originate from the pancreas and are hormonal in 
nature. 
METHODS 
Portal Diversion Procedures 
One hundred and one mongrel dogs, weighing 
12.4 to 24.1 kilograms, were used. Six normal dogs 
were sacrificed to obtain tissues for control studies 
and liver lobe weights, and the remaining 95 dogs 
had one of the following operative procedures. 
Group 7, partial portacaval transposition. a, Split 
transposition.-In 15 dogs, the left (Fig. 1al and in 
18 dogs the right (Fig. 1 b) portal vein was detached 
from the main portal trunk and revascularized by 
an end-to-end anastomosis to the supra-adrenal 
inferior vena cava by the method of Marchioro and 
his associates (28). The procedure divides the liver 
into two compartments which are dissimilar in that 
one receives portal blood from the total splanchnic 
venous bed and the other obtains its portal supply 
from systemic sources, including the effluent from 
the kidneys, adrenals, and hindquarters. 
b, Split transposition minus adrenal and renal in-
flow.- The procedure was identical to that just 
described except that the systemic venous blood 
was derived from the infrarenal inferior vena cava 
thereby excluding the renal and adrenal effluent. 
This blood was transmitted to the appropriate 
branch of the portal vein by way of an internal 
jugular vein graft. In six dogs, the systemic venous 
input was to the left portal branch (Fig. Ie) and in 
two dogs, to the right portal vein (Fig. Id). 
Group 2, splanchnic flow division. The two portal 
branches were isolated. One was left undisturbed; 
the other was detached and anastomosed by means 
of an iliac vein graft to the common mesenteric 
vein below the level of the splenic and pancreatic 
venous input. Proximally, the mesenteric trunk was 
ligated just below the splenic vein (Fig. 2). Thus, 
one side of the liver received portal blood of an 
intestinal source, and the other side received ve-
nous blood returning from the pancreatic, splenic, 
and gastroduodenal beds. Twenty experiments 
each were performed to the right and the left sides. 
In the dog, the pancreas has two distinct lobes. 
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FIG. 3. Techniques of transposition for the dogs in group 3. a, Standard 
portacaval transposition of Child. b, Modified transposition which elimi-
nates adrenal and renal venous blood from the portal blood samples. A 
venous graft is always required. 
Early in the series, it was discovered that the tail of 
the inferior pancreatic lobe almost invariably 
drains into the mesenteric venous circulation (Fig. 
2, insets). Thereafter, this portion of the pancreas 
was always resected at the time of the splanchnic 
division procedure. Three dogs operated upon 
before this observation was made had delayed par-
tial pancreatectomy at the time of the first biopsy 
one month after the original operation. 
Group 3, total portacaval transpositions. a, Standard 
transposition.-Nine dogs underwent portacaval 
transposition by means of Child's method (11) and 
as shown in Figure 3a. An open liver biopsy was 
performed before the transposition. 
b, Total transposition minus adrenal and renal 
inflow.-Five dogs had a modified portacaval 
transposition (Fig. 3b) with revascularization of the 
portal vein by means of a venous graft from the 
infrarenal inferior vena cava. 
Postoperative Studies 
The dogs were maintained on a standard kennel 
diet. Bilirubin, alkaline phosphatase, and serum 
glutamic oxalacetic transaminase values were 
checked twice a week. These values were never ab-
normal. 
Vessel patency. Prior to liver biopsy, the patency 
of the anastomoses was determined either by angi-
ography or at exploratory laparotomy. At angi-
ography of the dogs in groups 1 and 2, an effort 
was made to see if dye injected in one venous pool 
spilled into the other bed. Complete gross separa-
tion was always demonstrated. 
Liver biopsies. In all dogs found to have patency 
of the two portal branches, biopsy specimens were 
taken from both sides. To minimize any effects due 
to the anesthetic agents, the specimens were re-
moved under normothermia as soon as possible 
after induction of anesthesia with phencyclidine 
hydrochloride (Sernylan®), atropine, and pento-
barbital sodium. The liver was first carefully ex-
amined for gross evidence of hypertrophy or atrophy. 
Blood flow to the area of the biopsy was not inter-
fered with in any way until the specimen had been 
removed. In all experiments except those of group 
3, both sides of the liver were biopsied and the 
specimens processed separately. Two grams of liver 
tissue were excised. One and one-half grams of 
tissue were snap frozen within five seconds and 
stored in liquid nitrogen at -158 degrees C. until 
the biochemical studies were performed. The rest 
of the biopsy specimen was used for pathologic 
studies. A portion was fixed in formalin, and the 
remaining tissue was frozen with dry ice. 
Autopsy procedures. Most of the dogs were sacri-
ficed after the last biopsy. In the dogs in groups 1 
and 2, the liver was excised and extraneous tissue, 
including the gallbladder, trimmed from it. After 
weighing the entire liver, the two portal branches 
were carefully dissected out and a decision made 
as to the exact portal venous distribution to each of 
the lobes, and sublobes of the liver. When the entire 
liver had been thus subdivided into the right and 
left components, it was cut along that axis and the 
right and left portions weighed separately. The 
normal weight ratio for the right lobes versus the 
left lobes had been shown by Child (11), Marchioro 
(28), and Pouyet (34) and their associates to be 
about 30:70. Of the six normal control dogs which 
were sacrificed, these same proportions were veri-
fied as will be noted later. 
In dogs dying prior to biopsy, the same morpho-
logic evaluation for atrophy and hypertrophy was 
performed, and specimens were taken for his to-
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logic studies, but no arrangements were made for 
biochemical determinations. 
Criteria for ~ypertrophyK On histopathologic study, 
relative atrophy or hypertrophy of the different 
liver portions was usually evident, and differences 
in lobule size, fat content, reticulin pattern, and 
glycogen content could be detected with the ap-
propriate stains. 
To obtain a quantitative estimation of the hepa-
tocyte size, a tracing device was attached to the 
light microscope, and large numbers of hepa-
tocytes in each experiment were drawn on a stan-
dard thickness paper. Forty representative traced 
hepatocytes were then cut out, and the pieces of 
paper they occupied were weighed (Fig. 4). The 
weight in grams was used to denote size units. We 
have shown this to be an accurate method for com-
paring cell sizes by confirmatory planimetry and 
by studies of unicellular organisms, the size of 
which could be directly determined. 
Criteria for hyperplasia. The following hallmarks of 
hyperplasia were looked for: increased numbers of 
mitoses, the presence of binucleate and trinucleate 
hepatocytes, increased numbers of bile ductules, 
and increased thickness of the hepatic cell plates. 
Biochemical Determinations 
Hepatic glycogen. The method of Bloom and his 
associates (4) was used to separate the trichloro-
acetic acid soluble glycogen fraction from the in-
soluble one. Both fractions were quantitated with 
the anthrone method of Seifter and his colleagues 
(42), and the results were expressed in milligrams 
of glycogen per gram wet weight of liver. 
Active and total phosphorylase. The active form of 
hepatic phosphorylase, Enzyme Commission Num-
ber 2.4.11., was measured by the method of Shi-
mazu and Fukada (45), wherein additional activa-
tion during the assay of phosphorylase, Enzyme 
Commission Number 2.7.1.38., is prevented by 
inhibiting dephosphophosphorylase kinase and 
phosphorylase phosphatase, Enzyme Commission 
Number 3.1.3.17., with ethylenediaminetetra-
acetate and sodium fluoride, respectively. The 
assay for the phosphorylase determination con-
tained 50 millimoles of glucose-i-phosphate and 1 
per cent glycogen, to which a glycerol extract of 
liver was added. Incubation was for ten minutes at 
37 degrees C., following which the inorganic phos-
phate released was measured by the method of 
Takahashi (55). The activity of phosphorylase was 
expressed as millimicromoles of phosphate liber-
ated in one minute by 1 milligram of protein of 
liver extract. 
Total phosphorylase activity was assayed in the 
*l@ 
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FIG. 4. Hepatocyte shadows traced during histopatho-
logic examination. These were later cut out on standard 
paper and weighed as an index of hepatocyte size. The 
specimens depicted were from the experimental group 2 
(see Fig. 2a). The right lobes with the large hepatic cells 
received venous blood from the pancreas, stomach, duode-
num, and spleen. The relatively shrunken left lobes with the 
small hepatocytes received intestinal blood. 
same way except that inactive phosphorylase was 
first rendered active with adenosine triphosphate 
according to the method described by Shimazu and 
Amakawa (44). 
Hepatic cyclic 3', 5'-adenosine monophosphate (cyclic 
AMP). The method for extracting the liver sequen-
tially with trichloroacetic acid and cold water-
saturated diethyl ether has been described by 
Wastila and his associates (60). The extract was 
directly assayed for cyclic 3', 5'-adenosine mono-
phosphate by the protein binding method of Gil-
man (19). The values obtained represent the means 
of four determinations of each sample and are ex-
pressed as picomoles per gram wet weight of liver. 
Protein concentration. The protein of a weighed 
liver specimen was extracted with 10 per cent tri-
chloroacetic acid and digested with 3 per cent 
desoxycholic acid in sodium hydroxide. The pro-
tein concentration was then measured with the 
biuret method of Henry and his colleagues (21). 
Protein synthesis. Twenty-four hours before biopsy, 
the dogs were given an intravenous injection of 60 
millicuries of 14C-Ieucine which had a specific 
activity of 28.1 millicuries per millimole. A 70 to 
100 milligram portion of the biopsy specimen was 
processed by the method of Schneider and Hoge-
boom (41) as modified by Siekevitz (46), and the 
resulting protein powder was collected on a milli-
pore filter. The filters were introduced into count-
ing vials containing 20 milliliters of Albano and 
Francavilla's standard scintillation solution (1 ) and 
counted on a Picker Liquimat@, The results were 
expressed as counts per minute per gram wet 
weight of liver. 
Total lipids and triglycerides. Total lipids were mea-
sured by a modification of the method of Mac-
Kenzie and his colleagues (26), by which a tissue 
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FIG. 5. Changes in peripheral and portal venous insulin 
and hepatic cyclic 3/, 5' -adenosine monophosphate, cyclic 
AMP, occurring in a normal dog infused with tolbutamide. 
Note that the peak insulin response in the portal blood oc-
curred 25 to 40 minutes after infusion and that no significant 
alterations in hepatic cyclic 3/, 5'-adenosine monophosphate 
were caused acutely by the tolbutamide itself. 
sample is homogenized in and extracted with a 
cold 1:1 ethyl alcohol:ethyl ether solution, washed, 
dried, and weighed. 
The triglyceride fraction was extracted and 
weighed by a. modification of MacKenzie's micro-
method as derived from Barron and Hanahan (2), 
using silicic acid column chromatography to sepa-
rate the triglyceride from the other lipid compo-
nents. The column was first washed with 5 grams of 
85: 15 hexane: benzene. Then, the first two fractions 
of 4 grams each were eluted with a mixture of 97:3 
hexane:ethyl ether and collected for triglyceride 
determinations. 
The total lipids and triglyceride fractions were 
expressed as milligrams per gram wet weight ofliver. 
Glucokinase. Glucose phosphorylation by gluco-
kinase, Enzyme Commission Number 2.7.1.2., was 
assayed by the glucose-6-phosphate dehydrogenase 
spectrophotometric method of Salas and his col-
leagues (40). The results were expressed as micro-
moles of glucose phosphorylated per minute per 
gram wet weight of liver at room temperature. 
Kinetic Studies oj Cyclic 3', 5'-adenosine Monophosphate 
(Cyclic AMP) 
Aminophylline test. To determine the rate of for-
mation of liver cyclic 3', 5'-adenosine monophos-
ph ate, 13 dogs of groups 1 or 2 were submitted to 
an aminophylline infusion test two months after 
their operation. As described by Robison and his 
group (38),. the methylxanthines in appropriate 
dosages are essentially complete inhibitors of cyclic 
3', 5'-adenosine monophosphate phosphodiester-
ase. Since Butcher and Sutherland (8) and Cheung 
(10) have shown this phosphodiesterase to be the 
principal enzyme involved in the catabolism of 
cyclic 3', 5'-adenosine monophosphate, inhibition 
of the enzyme with aminophylline allowed the 
quantitation of cyclic 3', 5'-adenosine monophos-
phate formation. A large dosage of aminophylline 
was used. This was given rapidly to permit prompt 
completion of the studies before the onset of de-
layed physiologic effects, such as aminophylline-
induced changes in insulin levels which might by 
themselves affect the metabolism of cyclic 3', 5'-
adenosine monophosphate. 
The dogs were anesthetized, and open biopsy 
specimens of the right and left lobes were taken for 
base line levels. Then, 3 grams of aminophylline in 
300 milliliters of 5 per cent dextrose in normal 
saline solution were infused by way of a peripheral 
vein at a constant rate during a six minute interval. 
Biopsy specimens of 100 to 200 milligrams in 
weight were removed from both sides of the liver at 
two, four, and six minutes after the infusion was 
begun, taking care to minimize blood loss. These 
were immediately frozen in liquid nitrogen and 
assayed for cyclic 3', 5'-adenosine monophosphate 
as described previously. 
Tolbutamide-glucagon test. As reviewed by Exton 
and Park (13), the level of hepatic cyclic 3/, 5/-
adenosine monophosphate is, at least in part, under 
the control of endogenous insulin. To determine 
whether or not the livers of dogs remained respon-
sive to changes in insulin level after a portal diver-
sion procedure, a test was developed in which the 
cyclic 3/, 5'-adenosine monophosphate response to 
a measured dosage of endogenous insulin was 
measured. 
To generate a standard endogenous insulin re-
sponse, a 40 milligram per kilogram dose of tolbuta-
mide was given to normal dogs as a one minute 
infusion by way of a peripheral vein. With the 
insulin antibody method of Morgan and Lazarow 
(32), it was found that the peak of insulin increase 
in the portal blood occurs 25 to 40 minutes after 
the infusion of tolbutamide (Fig. 5). 
The tolbutamide itself did not cause major 
changes in hepatic cyclic 3/, 5'-adenosine mono-
phosphate (Fig. 5). Nevertheless, the levels of portal 
blood insulin generated by this test are known from 
other studies of Robison and his colleagues (38) to 
" 
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FIG. 6. Results with the tolbutamide-glucagon test in three dogs from groups la 
or 1 c in which there was clotting of the venous grafts. Consequently, the left branch 
of the portal vein transmitted no blood at all while the right lobes had a full 
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response to exogenous glucagon was considerably less in the lobes having a portal 
inflow compared with the lobes suffering from portal devascularization. The 
relatively lower cyclic 3', 5'-adenosine monophosphate presumably represented a 
restraining insulin effect. 
produce a reduction in .the hepatic cyclic 3', 5'-
adenosine monophosphate, even though these are 
so slight that they are difficult to measure by direct 
techniques. However, the effect of the insulin can 
be demonstrated by giving glucagon simultane-
ously, as was demonstrated in three control experi-
ments (Fig. 6). Glucagon normally produces a 
manyfold increase in liver cyclic 3', 5'-adenosine 
monophosphate when given by systemic vein, but 
when the liver received both endogenous insulin 
and exogenous glucagon simultaneously, the net 
effect was a more modest rise in cyclic 3', 5'-
adenosine monophosphate (Fig. 6). In these con-
trol dogs, the right lobes of the liver had a normal 
blood supply whereas the left portal branch was 
occluded so that the left lobes did not directly re-
ceive any venous effluent from the pancreas. 
The conditions of the tests in the 13 definitive 
dogs of groups 1 or 2 were as follows: the anesthe-
tized dogs were maintained on lactated Ringer's 
solution while biopsy specimens of each side of the 
liver were taken. Tolbutamide, 40 milligrams per 
kilogram body weight, was given intravenously for 
one minute, following which an infusion of 5 grams 
per kilogram of dextrose was given over 25 minutes, 
Then, 1.40 gammas per kilogram body weight of 
glucagon were given in 300 milliliters of 5 percent 
dextrose during eight minutes. Biopsy specimens 
were taken at two, four, six, and eight minutes after 
the glucagon infusion was begun, frozen in liquid 
nitrogen, and assayed for cyclic 3', 5'-adenosine 
monophosphate, as described previously. 
RESULTS 
Partial Portacaval Transposition 
Morphologic findings. Eighteen of the 33 experi-
ments with unmodified split transposition were 
carried to completion with proof of the patency of 
the venous channels after approximately two 
months. In 11 of these successful experiments, the 
inferior vena cava was anastomosed to the left 
portal branch (Fig. 1a), and in the other seven, the 
vena caval anastomosis was to the right branch 
(Fig.1b). 
The results which are partially summarized in 
Figure 7 confirmed and extended the observations 
previously reported from our laboratories (28, 30). 
The liver lobes receiving splanchnic venous inflow 
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TABLE I.-THE EFFECT IN SPLIT TRANSPOSITION EXPERIMENTS OF GROUP 1 OF PORTAL VENOUS INFLOW FROM 
THE SPLANCHNIC VERSUS THE INFERIOR VENA CAVAL BEDS 
Splanchnic flow 10 right lob« Splanchnic flow to left lobes 
_ __ One month-- ___ Two monlhs _______ One mont"--____ Two months ____ 
No. Right Left p No. Right Left P No. Right Left p No. Right Left p 
Glycogen, mgm./gm. 
of liver 
Total ............ 7 5.15 3.79 <0.02 11 3.74 2.26 <0.001 3 2.92 3.74 NS 7 2.45 4.66 <0.001 
± 1.00 ±0.43 ± 1.16 ± 1.08 ± 1.63 ±2.69 ±0.70 ±0.76 
Trichloroacetic acid 
soluble ........... 7 4.65 2.81 <0.02 11 3.00 1.59 <0.001 7 1.89 3.55 <0.01 
± 1.11 ±0.81 ± 1.03 ±0.88 ±0.83 ±0.58 
Cyclic adenosine 
monophosphate, pico-
moles/gm.ofliver .. 7 1,050 1,638 <0.001 11 1,162 1,695 <0.001 3 1,276 906 <0.1 6 1,718 1,363 <0.05 
±159 ±284 ±86 ±256 ± 185 ±211 ±96 ±267 
Phosphorylase, milli-
micro moles / min./ 
mgm. of liver protein 
Total ............. 7 111.5 
* 
11 123.1 
* 
3 
* 
123.5 NS 4 
* 
110.7 
±11.3 ±17.7 ±17.0 ± 10.1 
Active ............ 7 51.9 72.7 <0.1 11 54.8 76.0 <0.001 3 66.6 46.0 NS 4 72.3 44.8 <0.02 
±14.0 ±18.2 ±11.8 ± 13.2 ±18.4 ±12.3 ±4.3 ±6.1 
Glucokinase, micro-
moles/gm./min .... 9 3.04 1.73 <0.001 7 1.59 2.33 <0.01 
± 1.14l±0.67 ±0.97 ±0.81 
Protein concentration, 
mgm./ gm. of liver. 7 197.0 216.3 <0.05 11 205.4 211.7 NS 3 195.8 175.5 NS 7 188.5 184.2 NS 
±14.0 ±21.0 ±21.4 ±20.9 ±7.8 ±63.9 ±17.6 ±15.6 
Protein synthesis, 
counts/min./gm. 
of liver ........... 2,175 2,558 6 1,758 1,866 NS 2 2,016 2,021 NS 
± 112 ±246 ±378 ±243 
Triglycerides, mgm./ 
gm. of liver ....... 3 16.8 11.6 <0.1 
±3.0 ±1.6 
Means, numbers of determinations, and standard deviations are given. 
All p values compare the two liver sides. 
"'Within the limits of the analytic method used, the measurements oftatal phosphorylase activity were constant in a given experiment, no matter what the 
site of the liver biopsy. For this reason, these determinations are given only for the side of the liver receiving splanchnic blood. 
gained weight after 2 ± 0.5 (standard deviation) 
months and had striking hypertrophy of the indi-
vidual hepatocytes, whereas the lobes being per-
fused with vena caval blood shrank with a diminu-
tion of the liver cell size. Good histopathologic 
studies were obtained from 17 of the 18 livers. The 
liver lobules were larger on the splanchnic side in 
all of the 17 experiments, and lipid was less promi-
nent in 12 of 17 and about equal in the other five. 
Glycogen, as judged with periodic acid-Schiff 
stained sections, often seemed more prominent in 
the lobes supplied with splanchnic venous blood 
although this finding was inconstant. Consequently, 
heavy reliance was placed on the quantitative 
glycogen assays which will be described. 
There was also evidence of hyperplasia on the 
side receiving splanchnic blood. This consisted of 
the presence of hepatic cell plates two or more cells 
thick, binucleate and trinucleate hepatocytes, in-
creased numbers of bile ductules, and a slightly 
increased mitosis count. 
Of the eight attempts at split transposition with 
exclusion of the adrenal and renal blood, only one 
experiment was completely successful, that with 
vena caval flow to the right lobes (Fig. 1d). The 
morphologic effects of this procedure at nine weeks 
(Fig. 7) were comparable but slightly less extreme 
than with the regular split transposition. 
Biochemical concentrations. Beginning within four 
weeks and continuing until two months there were 
marked biochemical differences between the lobes 
according to the source of the portal venous inflow 
(Table I). Hepatic tissue receiving splanchnic 
blood, whether this be on the right or left side, had 
significantly higher concentrations of glycogen and 
glucokinase relative to the lobes supplied by vena 
caval blood. In contrast, the lobes supplied by the 
vena caval blood had significantly higher cyclic 3', 
S'-adenosine mono phosphate and active phos-
phorylase concentrations. The hepatic triglyceride 
concentration seemed to be increased by splanchnic 
venous inflow, but the observations were too few to 
permit statistical significance. The comparisons of 
protein concentration and protein synthesis were 
not strikingly different (Table I). 
In the one successful experiment of group 1 b 
(Fig. Id) in which adrenal and renal venous blood 
was exclud.ed from the vena caval supply to the 
· . 
Starzl et al.: HEPATOTROPHIC SUBSTANCES IN PORTAL VENOUS BLOOD 9 
LIVER/BODY WEIGHT (%) 
2.8 2.4 2.6 2.4 80 .16 
:05 :0.4 :1:0.4 
.12 If) 
I-
KMU~ 
RIGHT Z RIGHT 
LOBES .04- LOBES 4J 
N 
0 0--If) 
LEFT 4J LEFT .04 t-
LOBES >- LOBES u 
.oag 
c:( 
CL 
.12 4J 
J: 
.16 
6 10 7 6 
NO. OF EXPERIMENTS 
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right lobes, the chemical pattern was altered after 
nine weeks in a different way than in the dogs of 
group la. In the right and left lobes, respectively, 
glycogen was 5.7 and 5.25 milligrams, glucokinase 
was 1.0 and 1.5 micromoles, active phosphorylase 
was 47.4 and 45.3 millimicromoles, and cyclic 3', 
5'-adenosine monophosphate was 974 and 1,225 
picomoles. 
Splanchnic Flow Division 
Forty experiments were attempted, and 12 were 
carried to completion. In six successful experi-
ments, the pancreatic, splenic, and gastroduodenal 
blood passed to the right lobes (Fig. 2a), and in the 
other six this blood passed to the left lobes (Fig. 2b). 
Morphologic findings. The effects of these altera-
tions on the liver tissues after one to five and one-
half months, 73± 53 (S. D.) days, are summarized 
in Figure 8 and compared with the liver tissue from 
six normal dogs. The lobes which received the pan-
creatic, gastroduodenal, and splenic blood retained 
or increased their expected weight compared with 
the other lobes supplied by intestinal venous blood, 
and the individual hepatocytes in the favored lobes 
increased in size (Fig. 8). The latter hepatocyte and 
lobe size increases occurred whether the pancreatic, 
gastroduodenal, and splenic flow was to the left or 
right lobes. In addition to the hepatocyte size, com-
plete histopathologic analysis was performed on all 
12 livers. In nine of these 12 experiments, the liver 
lobules were obviously larger on the side supplied by 
the pancreatic-gastroduodenal-splenic venous efRu-
ent (Fig. 9). The degree of lipid deposition was less 
on this side in one experiment but about the same 
in the other 11. 
There was also evidence of hyperplasia in the 
liver tissue supplied by blood from the pancreas, 
stomach, duodenum, and spleen (Fig. 9). This 
consisted of hepatic cell plates two or more cells 
thick, binucleate and trinucleate hepatocytes, and 
increased numbers of bile ductules. A slightly raised 
mitosis count was also found in those livers biopsied 
less than three months after splanchnic flow 
division. 
Biochemical concentration. After 10.4 ± 7.6 (S. D.) 
weeks, range one to five and one-half months, the 
liver tissue provided with pancreatic-gastroduo-
denal-splenic blood contained higher concentra-
tions of glycogen in spite of the fact that alimentary 
glucose was passing primarily to the contralateral 
hepatic lobes. These findings were statistically sig-
nificant in the experiments of group 2b in which 
the pancreatic-gastroduodenal-splenic blood went 
to the left lobes (Table II). When this blood was 
directed to the right side in the dogs in group 2a, 
the right lobes behaved similarly, but the changes 
were short of statistical significance. Under both 
conditions, the glucokinase was elevated in parallel 
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TABLE n.-THE EFFECT IN SPLANCHNIC DIVISION EXPERIMENTS OF GROUP 2 OF PERFUSING THE LIVER WITH 
PANCREATIC DUODENAL SPLENIC VERSUS INTESTINAL BLOOD 
~planchnic flow to right lobes Splanchnic flow to left lobes 
__ One mont"-- __ Two months ___ ___ One month ___ Two months ___ 
No. Right Left P No. Right Left p No. Right Left P No. Right Left p 
Glycogen, mgm./gm. 
of liver 
Total ............ 5 5.28 5.26 NS 4 3.64 3.13 NS 4 3.31 4.51 <0.02 6 2.83 4.07 <0.01 
±1.26 ± 1.47 ± 1.63 ± 1.67 ± 1.90 ±1.91 ± 1.87 ±1.64 
Trichloroacetic acid 
soluble ... '" ..... 4.11 4.03 NS 4 3.35 2.35 NS 4 2.93 3.70 <0.1 6 2.00 3.23 <0.001 
±1.05 ±1.05 ±Oo4O ± 1.55 ± 1.90 ±2.05 ±1.31 ±lo4l 
Cyclic adenosine 
monophosphate 
picomoles/gm. of 
liver ............. 5 1,276 1,258 NS 4 1,215 1,123 NS 4 725 1,052 NS 6 1,077 1,164 <0.1 
±102 ±76 ±191 ±175 ±63 ±394 ±237 ±218 
Phosphorylase, 
millimicromoles / min./ . 
mgm. of liver protein 
Total ............ 5 115.1 * 4 104.2 * 4 * 88.8 6 * 113.2 
±21.3 ±604 ±23.5 ±11.6 
Active ............ 4 46.5 48.1 NS 4 52.0 5004 NS 4 43.2 47.3 NS 6 49.2 48.5 NS 
±10.0 ±7.3 ±6.3 ±6.3 ±4.8 ±15.0 ±7.9 ±7.3 
Glucokinase, micro-
moles/gm./min .... 4 2.16 1.62 <0.1 4 2.07 2.67 NS 
±1.27 ± 1.06 ±1.13 ±0.88 
Protein concentration, 
mgm./gm. of liver. S 188.3 190.7 NS 4 205.6 20204 NS 4 179.0 210.0 <0.02 6 192.7 198.2 NS 
±35.9 ±29.9 ±2.5 ±6.2 ±7.0 ±19.8 ±33.1 ±33.9 
Protein synthesis, 
counts/min./gm. 
of liver ........... 4 2,696 2,753 NS 4 2,971 3,021 NS 3 2,340 2,509 NS 
±394 ±358 ± 1,044 ± 1,043 ±970 ±341 
Means, number of determinations, and standard deviations are given. 
All p values compare the two sides. 
*Within the limits of the analytic method used, the measurements of total phosphorylase activity were constant in a given experiment, no matter what the 
site of the liver biopsy. For this reason, these determinations are given only for the side of the liver receiving splanchnic blood. 
TABLE IlI.-THE EFFECT OF PORTACAVAL TRANSPOSITION (LEFT) AND PORTACAVAL TRANSPOSITION MINUS 
THE RENAL AND ADRENAL BLOOD (RIGHT) UPON GLYCOGEN CONCENTRATION AND CYCLIC 3/, 5 '-ADENO-
SINE MONOPHOSPHATE 
Transpositioft Transposition minus renal, adrenal 
Xo. Preoperative Postoperative p Xo. Preoperative Postoperative p 
Glycogen, mgm./gm. 
of liver 
Total .............. 5 3.82±0.53 2.10± 1.04 <0.02 2 4.08± 1.12 2.27±Oo4O NS 
Trichloroacetic ac id 
soluble ............ 5 3.13±Oo42 t.70±0.83 <0.001 2 2.99±0.55 1.89±0.31 NS 
Cyclic adenosine 
mono phosphate, pico-
moles/gm.ofliver ... 5 (1107)* 1,729±215 <0.01 2 (1107)* 1,701±46 <0.05 
The experiments a'" group 3a and 3b. 
All P values compare the preoperative and postoperative determinations. 
"This "normal"for cyclic 3', 5'-adenosine monophosphate was derived by taking the mean of a series of cyclic 3/, 5'-adenosine monophosphate determina-
tions in biopsy specimens taken from canine livers having a normal portal blood supply, 
with the glycogen but not to a statistically signifi-
cant degree (Table II). 
Cyclic 3', 5'-adenosine monophosphate, active 
phosphorylase, protein concentration, and protein 
synthesis did not conform to a consistent pattern. 
Total Portacaval Transposition 
The five dogs with successful conventional trans-
position (Fig. 3a) underwent follow-up study for 
10.2±2.0 (S. D.) weeks, and the dogs with trans-
position minus adrenal and renal blood were each 
studied for two months. At autopsy, the per cent of 
liver to total body weight was 1.8 and 1.9 per cent 
in the respective groups. 
The dogs with standard as well as those with 
modified portacaval transposition had hepatic 
deglycogenation and striking elevations in cyclic 
3', 5'-adenosine mono phosphate (Table lIn. 
Kinetic Studies 
Partial portacaval transposition. In four of five dogs 
of groups la (Fig. la or b), the rate of cyclic 3', 5'-
Starzl et al.: HEPATOTROPHIC SUBSTANCES IN PORTAL VENOUS BLOOD 11 
LIVER/BODY WEIGHT (%)80 .16 
RIGHT 
LOBES 
LEFT 
LOBES 
2.8 2.9 2.7 
:1:0.5 :1:0.3 :1:0.4 
6 6 6 
I- 60 
J: 
~ 40 
W 
3: 
0:: 20 
w 
> 
::::i-o 
IL. 
020 
I-
Z 
W 40 
U 
0:: 
~ 60 
80 
.12 If) ........ ...,'0" 
I-
MU~ 
Z 
.04 -
W 
N 
O-in 
W 
.041-
>-
U 
.08g 
it 
.12 ~ 
.16 
RIGHT 
LOBES 
LEFT 
LOBES 
NO. OF EXPERIMENTS 
FIG. 8. The morphologic consequences of splanchnic venous flow 
division in the dogs in group 2 compared with normal dogs after 28 
to 173 days, average 73. The liver fractions which were perfused with 
venous blood from the pancreatic, gastroduodenal, and splenic areas 
are shaded. Note that these portions gained weight and underwent 
an increase in hepatocyte size relative to the other side while the 
total liver weight to body weight ratios were little altered. One stan-
dard deviation is depicted graphically on the bar graphs and written 
out for the weight percentages. 
adenosine monophosphate formation, as unmasked 
by the aminophylline test, was greater in the liver 
tissue receiving vena caval blood than in the con-
tralateral lobes receiving splanchnic venous blood 
(Fig. 10). 
In the single successful experiment in which par-
tial transposition was with vena caval blood minus 
adrenal and renal inflow (Fig. 1d), the cyclic 3', 
5'-adenosine monophosphate response showed a 
different pattern in that the side of the liver sup-
plied with vena caval blood had a much slower rate 
of cyclic 3', 5' -adenosine monophosphate accumu-
lation than the lobes receiving splanchnic blood 
(Fig. 11). These results were similar to those in 
three control experiments in which one side of the 
liver did not have a portal vein inflow at all due to 
clotting. This side accumulated cyclic 3', 5'-
adenosine monophosphate much more slowly than 
in the fully vascularized lobes (Fig. 12). 
With the tolbutamide-glucagon test, the lobes 
receiving nonhepatic splanchnic blood showed a 
response similar to that of the control dogs, whereas 
the contralateral lobes supplied with supra-adrenal 
vena caval blood showed a rapid accumulation of 
cyclic 3', 5'-adenosine monophosphate (Fig. 13). 
Splanchnic flow division. With the aminophylline 
infusion test, it was found in four experiments that 
the lobes receiving splenic-gastroduodenal-pan-
creatic blood had a more rapid rate of cyclic 3', 5'-
adenosine monophosphate synthesis than the con-
tralaterallobes supplied with intestinal blood (Fig. 
14). 
However, the lobes with splenic-gastroduodenal-
pancreatic venous inflow were found by the tol-
butamide test to be under insulin control in that 
three of five experiments showed a much slower 
rate of cyclic 3', 5'-adenosine monophosphate 
accumulation in response to exogenous glucagon 
than in the lobes receiving mesenteric blood (Fig. 
15). 
DISCUSSION 
Little doubt remains that there are substances in 
splanchnic venous as opposed to systemic venous 
blood that are important for the maintenance of 
hepatic structure and function. The first steps by 
which this concept was developed and validated 
have already been mentioned. The extent of pres-
ent day acceptance of the concept can be appreci-
ated by the fact that Fisher and Lee and their 
associates (15-17, 24), who until recently were the 
most outspoken critics of the hepatotrophic hypoth-
esis, have lately supported the idea. By adapting the 
double liver fragment principle introduced during 
investigation of auxiliary liver transplantation in 
our laboratory (28, 30, 51), they and their col-
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FIG. 9. Photomicrographs of sections from a liver which had been subjected to 
splanchnic flow division. The part of the liver supplied by the pancreaticogastro-
duodenal-splenic blood, panels on left, shows enlargement of the liver lobules, 
abundant glycogen, and hypertrophy and hyperplasia of hepatocytes when com-
pared with the part supplied by intestinal blood, panels on right. Upper, Reticulin 
stain, X10. Middle, Periodic acid-Schiff, X87. Lower, Hematoxylin and eosin, X87. 
leagues have added convincing evidence of their 
own supporting the hepatotrophic theory (9, 18, 
25). 
The advantage of the various double or split 
liver preparations for the investigation of hepato-
trophic mechanisms is that the hepatotrophic fac-
tors are apparently exhausted by exposure to one 
hepatic fragment and, therefore, are unavailable to 
other competing liver tissue if the latter is endowed 
with a blood supply deficient in such substances. 
With a single liver, as historically was used in 
studies of Eck fistula or portacaval transposition, 
the unmasking and precise study of splanchnic 
hepatotrophic effects was difficult or impossible 
after the portal by-pass procedures since biologi-
cally active substances in the diverted splanchnic 
venous effluent were presumably returned to the 
liver by way of the systemic blood although in di-
luted concentrations. Parenthetically, a recircula-
tion effect could account for the superior liver state 
of dogs with Child's transposition compared with 
animals with Eck fistula since the quantity of di-
luted hepatotrophic substances reaching the liver 
would be proportional to the total hepatic blood 
flow which is more than twice as great with trans-
position than with Eck fistula. Then, the classical 
error in interpretation followed, namely to assume 
that the quantity of blood flow was infinitely more 
important than the quality of the blood in main-
taining hepatic structure and function. 
Conceding the qualitative special ness of portal 
venous blood, the experiments in this study were 
designed to answer two sets of additional questions. 
The first concerned the source and the nature of the 
hepatotrophic factors in splanchnic venous blood. 
The second was involved with the mechanism of 
action of this factor or complex of factors. 
The origin of the hepatotrophic factors was 
determined from studies of the morphologic and 
biochemical changes induced in the liver by modifi-
cations of the portal venous inflow. These were of 
three types: total portacaval transposition, partial 
portacaval transposition, and splanchnic flow 
division. 
Q. 
:::?! 
<! ... Q) 
. :: 
u 
-l 
U e> 
>- ...... 
u (/) Q) 
'0 
u E 
I- 0 <J 
~ c. 
I..LJ 
J: 
Starzl et al.: HEPATOTROPHIC SUBSTANCES IN PORTAL VENOUS BLOOD 1.'3 
LOBES WITH SPLANCHNIC 
VENOUS INFLOW 
LOBES WITH VENA 
CAVAL INFLOW 
8,000-,----------,----------., 
6,000 
4,000 
2,000 
RIGHT 
/~~-;:." ,.,.", ~ 
~ 
,,-
:::.':"_._ ...... 
o 2 4 6 o 
LEFT 
.t' ,,'/ 
1 / 
. / 
1/ 
I~ .. :I~ / 
~ ... 
, ~ 
., ' ..... 
2 4 6 
8,OOO.,-----------r----------, 
LEFT RIGHT 
6,000 
4,000 
2,000 
02460246 
TIME AFTER BEGINNING AMINOPHYLLINE INFUSION 
(min.) 
FIG. 10. Aminophylline infusion tests in five dogs with partial portacaval 
transposition. In all but one, the rate offormation of cyclic 3', 5'-adenosine 
monophosphate was greater in the lobes deriving their portal inflow from 
the inferior vena cava although these differences were usually not obvious 
until several minutes had gone by. 
LOBES WITH SPLANCHNIC LOBES WITH INFLOW FROM 
VENOUS INFLOW INFRARENAL VENA CAVA 
Q. 8000 LEFT RIGHT 
:::?!~ 
<! Qj 
u~ 6000 
-le> 
u ...... 
>- Ul U Q) 4000 
'0 
U E 
- 0 I- <J 2000 <! .-Q. c. 
fKKig~ 
J: 
0 
TIME 
0246024 
AFTER BEGINNING AMINOPHYLLINE 
(min.) 
6 
INFUSION 
FIG. 11. Rate of cyclic 3', 5' -adenosine monophosphate formation, as 
measured by the aminophylline infusion test, in the single successful ex-
periment of group ld. 
The observations of Marchioro and his associ-
ates (28, 30) were first confirmed in experiments 
with partial transposition. Within four to eight 
weeks, liver lobes supplied with splanchnic venous 
inflow had hypertrophic glycogen-rich hepatocytes 
which in addition often had findings of hyperplasia. 
In contrast, the other lobes of the liver supplied by 
vena caval blood underwent involutional changes. 
The hepatocytes became smaller, and the glycogen 
concentration decreased, 
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division in four dogs. Cyclic 3', 5'-adenosine monophosphate synthesis 
was much more rapid in the hepatic lobes receiving pancreatic-gastro-
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intestinal venous effiuent. 
Next, surgical techniques were used that par-
titioned the splanchnic flow. The major part of the 
hepatotrophic influence as manifested both by 
morphologic and biochemical criteria was unequiv-
ocally shown to -be in the blood returning from the 
pancreas, proximal part of the duodenum, stom-
ach, and spleen. In contrast, the other hepatic 
lobes fed by nutritionally rich venous blood from 
the small intestine underwent involutional changes, 
including atrophy (Fig. 16) and deglycogenation 
nearly as profound as if a vena caval supply had 
been used. 
For several years, there has been good reason to 
suspect that the upper splanchnic organ complex 
and specifically the pancreas was the source of the 
hepatotrophic factors. In the studies of the blood 
flow requirements for auxiliary hepatic transplan-
tation by Marchioro and his colleagues (29), 
atrophy of the native liver could be minimized 
by provision of pancreatic-gastroduodenal-splenic 
blood even though all the rest of the splanchnic 
venous blood went to a co-existing liver homograft. 
Pouyet and his associates (34) came to the same 
general conclusion with carefully documented 
splanchnic division experiments similar to those in 
group 2 of this study. The correctness of these ob-
servations was later confirmed in a beagle homo-
transplantation model used by Ranson and his 
associates (37). In all these studies as well as in 
those reported herein, a contribution to the hepato-
trophic support of the liver could hypothetically 
have been made from the stomach, duodenum, or 
spleen although some of Pouyet's experiments es-
sentially ruled out the spleen and stomach. Never-
theless, it was logical as Price and his associates 
(35) have suggested to look for a hormonal explana-
tion. This was done in the present study with a 
series of biochemical evaluations. 
The first step was to analyze the hepatic changes 
caused by the classical portacaval transposition of 
Child and his associates (11), a procedure which 
profoundly deglycogenates the liver (43, 52) as was 
confirmed in the present study, deprives it of access 
to pancreatic hormones until after recirculation by 
way of the hepatic artery or systemic venous blood, 
and subjects the whole organ more or less continu-
ously to endogenous epinephrine. Since Sutherland 
and RaIl (53) and Murad and his associates (33) 
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venous blood. 
have shown that epinephrine works by the activa-
tion .of adenyl cyclase and the consequent formation 
of cyclic 3', 5'-adenosine monophosphate, the find-
ing of elevated concentrations of cyclic 3', 5'-
adenosine monophosphate in the total transposition 
livers of the dogs in group 3a was consistent with 
the concept that epinephrine was being excreted in 
large enough quantities to playa significant role in 
the deglycogenation. Nevertheless, proof that direct 
hepatic perfusion by endogenous epinephrine was 
not the only factor promoting these changes was 
provided by the experiments of group 3b in which 
transposition minus the adrenal and renal blood 
was successfully carried out in two dogs. Falls in 
hepatic glycogen concentration and rises in cyclic 
3', 5'-adenosine monophosphate occurred of al-
most the same magnitude as in the standard trans-
position. Here, it might be suggested that adrenal 
secretions which by-passed the liver were recircu-
lated to the organ after passing through the cardiac 
mixing chamber and even the peripheral capillary 
beds. Obvious atrophy was not produced in these 
transposition livers with or without direct provision 
of adrenal venous blood. 
In the split transposition experiments of group 
1a, increases in cyclic 3', 5'-adenosine monophos-
phate similar to those caused by a standard trans-
position were found in the deglycogenated and 
atrophic lobes of the liver receiving supra-adrenal 
vena caval blood as compared with the lobes sup-
plied with splanchnic venous blood. In these exper-
iments, the increases of activated glycogen phos-
phorylase and the decreases in triglyceride con-
centration in the lobes perfused with vena caval 
blood were consistent with the metabolic conse-
quences of epinephrine infusion and increased 
cyclic 3', 5'-adenosine monophosphate, as sum-
marized by Himms-Hagen (22). The fact that the 
concentration of endogenous epinephrine was 
physiologically significant was also suggested by 
some of the portal angiograms in the split transpo-
sition experiments which showed relative vasocon-
striction in the lobes being perfused by supra-adrenal 
vena caval blood. Thus, it was not surprising in the 
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one successful split transposition experiment in group 
1 b that exclusion of the adrenal and renal venous 
blood from the lobes supplied by the inferior vena 
cava curtailed both the rise in cyclic 3', 51-adeno-
sine monophosphate and the fall of glycogen con-
centration although atrophy was not thereby pre-
vented. These last findings were in contrast to the 
observations discussed in the preceding paragraph 
in the livers of two dogs that had total transposition 
minus the adrenal and renal blood. The apparent 
disparities indicated once more that influences 
other than the adrenal secretions were of impor-
tance in regulating cyclic 3', 5'-adenosine mono-
phosphate levels and in determining atrophy or 
hypertrophy. They focused attention upon the 
crucial role of the pancreas. 
Such a pancreatic role may be assumed to be due 
to the interactions of glucagon and insulin for 
which cyclic 3', 5'-adenosine monophosphate also 
represents a secondary messenger system. Like 
epinephrine, pancreatic glucagon increases cyclic 
3', 5'-adenosine monophosphate as demonstrated 
by the classical studies of Sutherland and Rall (53), 
setting in motion multiple chemical processes. Ber-
gen (3) and Weintraub (61) and their associates 
described the resulting glycogenolysis. Gluconeo-
genesis has been documented by Exton and Park 
(14), lipolysis by Butcher and his associates (6), and 
ketogenesis by Menahan and Wieland (31) as well 
as by Exton and his group (2). 
As reviewed by Exton and Park (13), Sutherland 
and Robison (54), and Robison and his colleagues 
(38), insulin promotes many converse metabolic 
events by depression of the basal level of cyclic 3', 
5'-adenosine monophosphate, thus qualifying as an 
anabolic hormone. Besides aiding glycogen synthe-
sis by the cyclic 3', 5'-adenosine monophosphate 
mechanism, Salas and his co-authors (40) have 
shown that insulin supports glycogen metabolism 
by increasing hepatic glucokinase, and Larner (23) 
has demonstrated activation of glucose transferase. 
Consequently, in the liver partition experiments of 
groups 1 and 2, it was not surprising that gluco-
kinase levels were elevated on the side of pancreas 
inflow and reduced on the side receiving either 
vena caval or intestinal flow. Butcher (7) and 
Robison (38) and their colleagues have shown that 
insulin regulates lipid synthesis by inactivating 
lipolytic enzymes through a lowering of cyclic 3', 
5'-adenosine monophosphate levels. Insulin also 
controls protein synthesis by a mechanism that is 
not understood. 
The fact that glucagon and insulin have partially 
cancelling effects helps explain why the cyclic 3', 
5'-adenosine monophosphate levels in liver lobes 
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FIG. 16. Summary from the different experiments de-
picted in Figures 1 and 2 shows the influence of the type of 
portal inflow upon hepatocyte size. The data are taken from 
Figures 7 and 8 and are compared with values obtained 
from the livers of normal dogs. Note that the presence of 
hypertrophy or atrophy was almost exclusively under the 
control of pancreatic-gastroduodenal-splenic blood and that 
the addition or subtraction of blood from other sources was 
of little further consequence. 
with an inflow of pancreatic venous blood tended 
neither to be very high nor very low. In turn, it 
helps explain why in the experiments of group 2 
significant differences could not be demonstrated 
between the cyclic 3', 5'-adenosine mono phosphate 
levels of liver lobes receiving pancreatic venous 
blood versus those receiving the hormone-poor 
effluent from the small intestine. 
The aforementioned biochemical studies pro-
vided insight about how various hormones could 
affect the liver. However, since cyclic 3', 5'-
adenosine mono phosphate is destroyed so rapidly, 
mainly by the enzyme cyclic 3', 5'-adenosine 
mono phosphate phosphodiesterase, accurate evalu-
ation of the rate of its production by the simple 
measures of its tissue concentration was not pos-
sible. Consequently, in several special experiments 
on the dogs of group 1, aminophylline was used to 
block the phosphodiesterase. The considerable 
extent to which the rate of .cyclic 3', 5'-adenosine 
monophosphate production was increased in the 
hepatic tissue exposed to adrenal venous blood 
could then be determined. 
The same kind of information was obtained in 
the livers of group 2 dogs in which neither hepatic 
side received adrenal venous blood directly. The 
aminophylline test uncovered a striking difference 
between the two sets of liver lobes. The rate of cy-
clic 3', 5'-adenosine monophosphate production 
was retarded in the liver lobes receiving blood from 
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the intestine but was essentially normal in the lobes 
receiving pancreatic-gastroduodenal-splenic blood. 
It might be suggested that the lobes receiving blood 
from the intestines in such experiments should have 
higher cyclic 3', 5'-adenosine monophosphate 
levels if there were an unopposed presence of in-
testinal glucagon. However, Unger (58) and Val-
verde (59) and their associates have shown that this 
substance which has some physiologic qualities 
similar to pancreatic glucagon and which in addi-
tion cross reacts with antiglucagon antibodies does 
not affect the level of hepatic cyclic 3', 5'-adenosine 
monophosphate when injected into the portal cir-
culation of the dog or into the perfusate nourishing 
an isolated rat liver. . 
The role of insulin in controlling the level of 
cyclic 3', 5'-adenosine mono phosphate was further 
documented by the tolbutamide-glucagon infusion 
test. In this experiment, measurable increases in 
endogenous portal insulin were caused by an in-
jection of tolbutamide. This was followed by the 
intravenous administration of exogenous glucagon. 
In all the experiments performed, there was a strik-
ing difference in the production of cyclic 3', 5'-
adenosine monophosphate between the liver sides 
according to the type of blood supply, indicating 
once again a profound metabolic dissociation. 
Hepatic lobes perfused with pancreatic blood and, 
thus, under insulin influence had modest or no rises 
in cyclic 3', 5'-adenosine monophosphate in spite of 
the exogenous glucagon whereas the other lobes 
had uninhibited increases. 
The data accumulated in this study leave little 
doubt that the previously nebulous hepatotrophic 
factors in splanchnic venous blood are hormones 
and that the major anabolic hormone is insulin 
counterbalanced to an unknown degree by the 
opposing effects of glucagon and possibly epineph-
rine as well. The interrelationship of these hor-
mones determines the chemical environment of the 
liver thereby influencing its function and structure. 
In most of the experiments herein reported, the 
competing liver fragment preparation developed 
during research on auxiliary hepatic transplanta-
tion was the experimental tool whereby the meta-
bolic dissociation and morphologic changes caused 
by different hormone exposure easily could be 
exposed and examined. But the findings in this 
special experimental model have major implica-
tions in normal as well as abnormal hepatic physi-
ology. 
For example, the reason for the liver atrophy 
caused in animals by the performance of Eck fistula 
obviously involves hormone deprivation. Explana-
tions of a similar kind can be easily formulated for 
other portoprival states, including those caused in 
man by portacaval anastomosis of a portal vein 
which has significant residual hepatopetal flow. 
Why portal diversion procedures have been of such 
great value for children with certain of the glycogen 
storage diseases (52) becomes evident. Even in 
attempts at liver preservation, it may be suggested 
that long term conservation by perfusion is not apt 
to be successful unless the chemical and hormonal 
constituency of the perfusate is made to simulate at 
least some of the features of portal blood. 
Although numerous other examples could be 
cited of the potential importance of hormonal 
mechanisms affecting the liver, attention will be 
focused only upon the virtual certainty that such 
hormonal factors are central to an understanding 
of hepatic regeneration. The way in which the por-
tal hormone constituents can direct liver regenera-
tion will require further detailed study from which 
clarification of some confusing past claims should 
emerge. A number of authorities on hepatic regen-
eration, including Sigel (48), Fisher (18), and 
Price (35) and their colleagues, have suggested that 
hypertrophy and hyperplasia are dissociated 
phenomena during regeneration. Price and his 
associates (35) have stated that there actually is a 
reciprocal relation,hip between hypertrophy and 
hyperplasia. The latter authors believe that hyper-
trophy is controlled by endogenous glucagon, and 
that hyperplasia is determined by some factor. re-
leased by the liver itself. 
Almost all the experiments purporting to show a 
dissociation between hepatocyte hypertrophy and 
hyperplasia have involved studies of deoxyribo-
nucleic acid or ribonucleic acid synthesis or cell 
mitosis counts within a few hours or days after a 
major traumatic procedure. In our own studies 
which permitted chronic observations, hypertrophy 
and hyperplasia occurred together, although not 
necessarily in absolute parallel, in hepatic frag-
ments supplied by either total splanchnic blood or 
blood from organs in the upper part of the abdo-
men whereas atrophy and the absence of hyper-
plasia were found in liver tis:,ue deprived of the 
appropriate splanchnic influence. These observa-
tions indicate that hypertrophy and hyperplasia 
are associated rather than dissociated, a point of 
view more in accord with the majority of regen-
eration studies which were recently reviewed by 
Bucher (5). 
The findings are also consistent with the hypoth-
esis that the hormonal hepatotrophic substances 
which have been the subject of this article are, in 
fact, the essential control factors of or at least play 
a vital role in hepatic regeneration. 
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SUMMARY 
The origin of hepa totrophic factors in splanchnic 
venous blood was investigated by modifying the 
portal venous inflow to different parts of the canine 
liver while leaving the arterial blood supply and 
biliary drainage intact. 
In one variety of experiment, termed partial 
transposition, the liver portion perfused with the 
total splanchnic venous blood underwent weight 
gain and hepatocyte hypertrophy, hyperplasia, and 
glycogenation compared with the portion perfused 
with venous blood from the hindquarters, kidneys, 
and adrenal glands, but the combined weight of 
the total liver remained constant in spite of the 
rapidly evolving regional disproportions. The lobar 
changes were well developed within one to two 
months. At this time, the hepatic lobes supplied with 
splanchnic venous blood had higher concentrations 
of glucokinase and lower concentrations of cyclic 
3', 5'-adenosine monophosphate and active phos-
phorylase than the lobes receiving hindlimb and 
adrenorenal venous blood, indicating that the bio-
chemical environment of the different liver regions 
was drastically different by virtue of being under 
specific hormonal control. 
The dissociation was even more dramatically 
illustrated by dynamic studies in which the destruc-
tion of cyclic 3', 5'-adenosine monophosphate by 
phosphodiesterase was blocked with aminophylline 
thereby permitting estimation of the rate of forma-
tion of cyclic 3', 5'-adenosine monophosphate. In 
addition, the modifying effect of tolbutamide-
induced endogenous insulin upon exogenously 
administered glucagon was evaluated by serial 
determinations of cyclic 3', 5'-adenosine mono-
phosphate. These investigations with the amino-
phylline and tolbutamide-glucagon tests demon-
strated the anabolic role of insulin and the opposing 
roles of both glucagon and epinephrine in con-
tributing to liver homeostasis. Epinephrine and 
glucagon caused striking increases in cyclic 3', 5'-
adenosine monophosphate, and insulin had the 
converse effect. 
Another type of preparation involving partition 
of the splanchnic venous blood between the liver 
portions was termed splanchnic flow division. The 
substances responsible for the hepatic hypertrophy, 
hyperplasia, glycogenation, and weight gain were 
shown to emanate mainly, if not virtually exclu-
sively, from the pancreatic-gastroduodenal-splenic 
venous drainage. In contrast, intestinal nutritional 
substrate and hormones from the intestine or adre-
nal gland were not profoundly influential in either 
promoting or preventing the morphologic or glyco-
gen concentration changes. The concentrations of 
cyclic 3', 5'-adenosine monophosphate, phosphory-
lase, and glucokinase in the two sides of the liver did 
not follow as distinctive a pattern as in the partial 
transposition experiments. However, the amino-
phylline and tolbutamide-glucagon tests revealed 
the same type of major dissociation of cyclic 3' , 5'-
adenosine monophosphate as with the partial trans-
positions. Particularly impressive was the way in 
which trace doses of tolbutamide-induced endoge-
nous insulin on the side nourished by pancreatic 
venous blood restrained the cyclic 3', 5'-adenosine 
monophosphate response to exogenous glucagon, 
whereas the other liver fragment which was not so 
covered by insulin had completely uninhibited 
rises in cyclic 3', 5'-adenosine monophosphate. 
The conclusion from these experiments is that the 
hepatotrophic factors previously reported from our 
laboratories and by other investigators to be in 
splanchnic venous blood are pancreatic hormones 
and specifically insulin and glucagon. Of these, 
insulin is anabolic and glucagon is mainly catabolic 
but not exclusively so, since glucagon also has the 
anabolic effect of stimulating gluconeogenesis. The 
insulin-glucagon relationship and the interrelation-
ship of these hormones to others, such as epineph-
rine, in the moment to moment regulation of 
nutrient and hepatic homeostasis is a central fact 
of liver physiology that should reconcile a number 
of previously divergent opinions about portoprival 
syndromes, mechanisms of hepatic atrophy and 
hyperplasia, and the control of liver regeneration. 
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